Article Details

BioInvent inks antibody manufacturing agreement with Cantargia

Retrieved on: 2020-11-26 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

BioInvent inks antibody manufacturing agreement with Cantargia. View article details on hiswai:

Excerpt

It is a fully humanized <b>monoclonal antibody</b> targeting IL1RAP that has been designed to block the signaling of the inflammatory cytokines IL-1, IL-33 ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo